My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics Stock Investors

Based on 519,446 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AKBA
On average, investors allocate 3.27% of their portfolios to AKBA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 519,446 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AKBA

1.6%
Last 7
Days
3.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AKBA, out of 519,446 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AKBA Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$2.87
Closed
0.00%
$2.95
Increased
1.80%
$2.94
Closed
0.00%
$2.85
Based on the activity of 43,820 investors who made their portfolios public
The table shows changes in AKBA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AKBA Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMRNAmarin
4.68%
1.90%
0.63%
$1.54B
Healthcare
AGTCApplied Genetic Technologies
6.20%
2.88%
15.44%
$111.45M
Healthcare
SRPTSarepta Therapeutics
5.10%
3.90%
0.78%
$6.97B
Healthcare
XERSXeris Pharmaceuticals
4.55%
-0.28%
-6.60%
$283.09M
Healthcare
INOInovio Pharmaceuticals
4.48%
0.50%
4.64%
$1.55B
Healthcare
SRNESorrento Therapeutics
7.03%
0.94%
-4.94%
$1.86B
Healthcare
VYNEVYNE Therapeutics
1.02%
0.51%
-2.81%
$57.26M
Healthcare
OPKOpko Health
4.79%
-2.65%
1.77%
$2.96B
Healthcare
ALNAAllena Pharmaceuticals
5.98%
1.93%
0.98%
$56.36M
Healthcare
OBSVObsEva SA
6.51%
-0.83%
-4.33%
$180.89M
Healthcare
Based on the activity of 519,446 active portfolios
Open your Smart Portfolio

AKBA Investor Analysis

AKBA investors under 35

Under 35

4.1%
Last 30 days
Holdings Change
8.1%
of AKBA holders
are under 35
Average Segment Performance
Monthly Return1.51%
Beta1.42
Dividend Yield7.08%
AKBA investors between 35–55

Between 35–55

4.5%
Last 30 days
Holdings Change
56.8%
of AKBA holders
are between 35–55
Average Segment Performance
Monthly Return1.61%
Beta5.17
Dividend Yield26.84%
AKBA investors over 55

Over 55

4.2%
Last 30 days
Holdings Change
35.1%
of AKBA holders
are over 55
Average Segment Performance
Monthly Return1.62%
Beta1.26
Dividend Yield7.23%
Overview of age group and performance of AKBA stock investors
See who invests in AKBA according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
ENTBFEntheon Biomedical
BPTSBiophytis
BTTXMountain Crest Acquisition II
DNAGinkgo Bioworks Holdings
FTRPField Trip Health

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis